Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial

NCT06434896 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

1320

Enrollment

OTHER

Sponsor class

Conditions

Circulating Tumor DNA
Recurrence
Colon Cancer Stage II

Interventions

OTHER: ctDNA analysis after surgery

Sponsor

UMC Utrecht

Collaborators

[object Object]
[object Object]